CA2500907A1 - Vehicule d'administration topique de composes anti-inflammatoires - Google Patents

Vehicule d'administration topique de composes anti-inflammatoires Download PDF

Info

Publication number
CA2500907A1
CA2500907A1 CA 2500907 CA2500907A CA2500907A1 CA 2500907 A1 CA2500907 A1 CA 2500907A1 CA 2500907 CA2500907 CA 2500907 CA 2500907 A CA2500907 A CA 2500907A CA 2500907 A1 CA2500907 A1 CA 2500907A1
Authority
CA
Canada
Prior art keywords
set forth
composition
pharmaceutically active
active component
vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2500907
Other languages
English (en)
Inventor
Joseph Schwarz
Michael Weisspapir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpharx Inc
Original Assignee
Alpharx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharx Inc filed Critical Alpharx Inc
Priority to CA 2500907 priority Critical patent/CA2500907A1/fr
Publication of CA2500907A1 publication Critical patent/CA2500907A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
CA 2500907 2005-03-15 2005-03-15 Vehicule d'administration topique de composes anti-inflammatoires Abandoned CA2500907A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2500907 CA2500907A1 (fr) 2005-03-15 2005-03-15 Vehicule d'administration topique de composes anti-inflammatoires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2500907 CA2500907A1 (fr) 2005-03-15 2005-03-15 Vehicule d'administration topique de composes anti-inflammatoires

Publications (1)

Publication Number Publication Date
CA2500907A1 true CA2500907A1 (fr) 2006-09-15

Family

ID=36998156

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2500907 Abandoned CA2500907A1 (fr) 2005-03-15 2005-03-15 Vehicule d'administration topique de composes anti-inflammatoires

Country Status (1)

Country Link
CA (1) CA2500907A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009147269A1 (fr) 2008-06-06 2009-12-10 Laboratorios Alcalá Farma, S.L. Préparation topique d'ibuprofène
WO2010072958A3 (fr) * 2008-12-23 2012-01-12 Galderma S.A. Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
US9084754B2 (en) 2009-12-23 2015-07-21 Nuvo Research Inc. Highly permeating terbinafine formulation
CN114259461A (zh) * 2021-11-29 2022-04-01 海南全星制药有限公司 一种双氯芬酸钠凝胶及其制备方法
CN114577952A (zh) * 2022-04-13 2022-06-03 河南师范大学 基于疏水性低共熔溶剂液-液微萃取富集测定环境水样中抗病毒药物泛昔洛韦残留的方法
CN115916183A (zh) * 2020-01-10 2023-04-04 布里奥里生物技术公司 含有罗非昔布的局部用组合物及其制备和使用方法

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009147269A1 (fr) 2008-06-06 2009-12-10 Laboratorios Alcalá Farma, S.L. Préparation topique d'ibuprofène
WO2010072958A3 (fr) * 2008-12-23 2012-01-12 Galderma S.A. Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
EP2419082B1 (fr) * 2008-12-23 2020-01-22 Galderma S.A. Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
US9084754B2 (en) 2009-12-23 2015-07-21 Nuvo Research Inc. Highly permeating terbinafine formulation
CN115916183A (zh) * 2020-01-10 2023-04-04 布里奥里生物技术公司 含有罗非昔布的局部用组合物及其制备和使用方法
CN114259461A (zh) * 2021-11-29 2022-04-01 海南全星制药有限公司 一种双氯芬酸钠凝胶及其制备方法
CN114259461B (zh) * 2021-11-29 2023-09-12 海南全星制药有限公司 一种双氯芬酸钠凝胶及其制备方法
CN114577952A (zh) * 2022-04-13 2022-06-03 河南师范大学 基于疏水性低共熔溶剂液-液微萃取富集测定环境水样中抗病毒药物泛昔洛韦残留的方法
CN114577952B (zh) * 2022-04-13 2023-08-04 河南师范大学 基于疏水性低共熔溶剂液-液微萃取富集测定环境水样中抗病毒药物泛昔洛韦残留的方法

Similar Documents

Publication Publication Date Title
US7781429B2 (en) Vehicle for topical delivery of anti-inflammatory compounds
US20060241175A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
EP1858556A1 (fr) Vehicule pour administration topique de composes anti-inflammatoires
US11123315B2 (en) Topical compositions for pain relief, manufacture and use
RU2754846C1 (ru) Обезболивающие композиции местного действия
US11666531B2 (en) Delivery system
JP5052558B2 (ja) ゲル軟膏
JP4549006B2 (ja) ゲル軟膏
JP2010521442A (ja) 局所製剤処方
CN106572970B (zh) 用于局部给药非甾体抗炎药以缓解肌肉骨骼疼痛的新型凝胶及其制备方法
CA2500907A1 (fr) Vehicule d'administration topique de composes anti-inflammatoires
JP2012092067A (ja) 非ステロイド性消炎鎮痛外用剤
EA029402B1 (ru) Трансдермальное средство для лечения и профилактики болезней суставов и мягких тканей, комбинированный трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей и способ его получения
KR101894891B1 (ko) 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형
KR20190101140A (ko) 비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물
JP2935113B1 (ja) インドメタシン経皮吸収剤
KR20240029152A (ko) 가려움증 치료제에 쓰일 수 있는 프로피온산계 비스테로이드성 약물을 유효성분으로 함유하는 외용 겔 제제의 제조법
JPH11343248A (ja) 局所タ―ゲティング用組成物
US20230302028A1 (en) Pain-relieving topical compositions
WO2020086038A2 (fr) Compositions topiques comprenant une combinaison de tolpérisone et d'inhibiteur sélectif de cox-2
TR2021007476A2 (tr) Kas gevşeti̇ci̇ ajanlar i̇le kombi̇nasyon hali̇nde i̇ndometazi̇n i̇çeren topi̇kal bi̇leşi̇mler
KR20200004277A (ko) 비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20120315